All Stories

  1. Testicular Volume of 4 mL Is Not an Appropriate Marker of Pubertal Onset in a Subset of Boys Born Small for Gestational Age
  2. 46,XY DSD with Partial Gonadal Dysgenesis and Growth Failure in a Patient with 3q27.1 Microdeletion: Candidate Gene Curation After Exhaustive Literature Review
  3. Updated compendium of genes and variants associated with congenital hypogonadotropic hypogonadism: systematic review, classification pipeline, and network analysis
  4. Development and Function of the Ovaries and Testes in the Fetus and Neonate
  5. Disorders of Sex Development
  6. Quantification of eight clinically relevant serum adrenal steroids in infants by UHPLC-APCI-MS/MS
  7. Differences of sex development
  8. Clinical presentation of congenital hypogonadotropic hypogonadism in males with delayed puberty according to genetic etiology: a systematic review and meta-analysis after reclassification of gene variants
  9. The Importance of Clinical Categorization for a Successful Etiologic Diagnosis of Monogenic Disorders in 46,XY DSD
  10. Cryptorchidism is frequently associated with testicular dysfunction
  11. Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients
  12. Assessment of testicular function in boys and adolescents
  13. Nathalie Josso, MD, PhD, 1934–2022
  14. Identification of a Novel Variant in Myelin Regulatory Growth Factor by Next-Generation Sequencing Led to the Detection of a Clinically Inapparent Congenital Heart Defect in a Patient with a 46,XY Disorder of Sex Development
  15. Taming Idiopathic Central Precocious Puberty: High Frequency of Imprinting Disorders in Familial Forms
  16. Considerations when treating male pubertal delay pharmacologically
  17. Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
  18. Delayed Puberty Due to a WDR11 Truncation at Its N-Terminal Domain Leading to a Mild Form of Ciliopathy Presenting With Dissociated Central Hypogonadism: Case Report
  19. AMH Regulation by Steroids in the Mammalian Testis: Underlying Mechanisms and Clinical Implications
  20. Next-Generation Sequencing as First-Line Diagnostic Test in Patients With Disorders of Sex Development?
  21. Are We Prepared to Abandon the Idea of Sex Binarism? A Biomedical Perspective
  22. Genetics of reproductive endocrinology
  23. Recent advancement in the treatment of boys and adolescents with hypogonadism
  24. Disorders of Sex Development of Adrenal Origin
  25. Up-to-Date Clinical and Biochemical Workup of the Child and the Adolescent with a Suspected Disorder of Sex Development
  26. Clinical tools in the diagnosis of disorders of sex development: a switch from the hormonal to the genetics laboratory?
  27. Herramientas clínicas en el diagnóstico del desarrollo sexual anómalo: ¿del análisis hormonal al análisis genético?
  28. Growth, puberty and testicular function in boys born small for gestational age with a nonspecific disorder of sex development
  29. Diagnosis of Male Central Hypogonadism During Childhood
  30. AMH and AMHR2 Involvement in Congenital Disorders of Sex Development
  31. Noncanonical Wnt Signaling in the Integrity of the Blood-Testis Barrier and Sperm Release
  32. Gonadectomy in conditions affecting sex development: a registry-based cohort study
  33. Development and Validation of a Prediction Rule for Growth Hormone Deficiency Without Need for Pharmacological Stimulation Tests in Children With Risk Factors
  34. Expression of acid-labile subunit (ALS) in developing and adult zebrafish and its role in dorso-ventral patterning during development
  35. The Role of Androgen Signaling in Male Sexual Development at Puberty
  36. Editorial: Puberty: Recent advancements in its physiology and the management of its disorders
  37. Regulation of meiosis initiation in the mammalian testis: novel aspects
  38. Molecular mechanisms underlying AMH elevation in hyperoestrogenic states in males
  39. What Does AMH Tell Us in Pediatric Disorders of Sex Development?
  40. Síndrome de osteoporosis-pseudoglioma: a propósito de un caso pediátrico de osteoporosis primaria
  41. Androgen Treatment in Adolescent Males With Hypogonadism
  42. Male Hypogonadism and Disorders of Sex Development
  43. A novel heterozygous STAT5B variant in a patient with short stature and partial growth hormone insensitivity (GHI)
  44. p.R209H GH1 variant challenges short stature assessment
  45. Molecular Characterization of XX Maleness
  46. Safety of standardised treatments for haematologic malignancies as regards to testicular endocrine function in children and teenagers
  47. CYP26B1 declines postnatally in Sertoli cells independently of androgen action in the mouse testis
  48. A homozygous mutation in the highly conserved Tyr60 of the mature IGF1 peptide broadens the spectrum of IGF1 deficiency
  49. Importance of the Androgen Receptor Signaling in Gene Transactivation and Transrepression for Pubertal Maturation of the Testis
  50. Hypogonadism in Pediatric Health: Adult Medicine Concepts Fail
  51. Importance of the Androgen Receptor Signalling in Gene Transactivation and Transrepression for Pubertal Maturation of the Testis
  52. A mutation inactivating the distal SF1 binding site on the human anti-Müllerian hormone promoter causes persistent Müllerian duct syndrome
  53. Paediatric and adult-onset male hypogonadism
  54. Comparing the role of anti-Müllerian hormone as a marker of FSH action in male and female fertility
  55. Androgens downregulate anti-Müllerian hormone promoter activity in the Sertoli cell through the androgen receptor and intact steroidogenic factor 1 sites†
  56. Clinical and Etiological Aspects of Gynecomastia in Adult Males: A Multicenter Study
  57. Anti-Müllerian Hormone and Testicular Function in Prepubertal Boys With Cryptorchidism
  58. Anti-Müllerian Hormone Deficiency and Resistance
  59. Commentary on sperm DNA fragmentation testing clinical guideline
  60. Importance of Serum Testicular Protein Hormone Measurement in the Assessment of Disorders of Sex Development
  61. Characterization of four Latin American families confirms previous findings and reveals novel features of acid-labile subunit deficiency
  62. Puberty arises with testicular alterations and defective AMH expression in rams prenatally exposed to testosterone
  63. Juan Jorge Heinrich, MD, PhD, 1937–2016
  64. Global Application of the Assessment of Communication Skills of Paediatric Endocrinology Fellows in the Management of Differences in Sex Development Using the ESPE E-Learning.Org Portal
  65. Most Cleaved Anti-Müllerian Hormone Binds Its Receptor in Human Follicular Fluid but Little Is Competent in Serum
  66. 46,XX ovotesticular DSD associated with aSOX3gene duplication in aSRY-negative boy
  67. Assessment of pathogenicity of natural IGFALS gene variants by in silico bioinformatics tools and in vitro functional studies
  68. Disorders of Sex Development with Testicular Differentiation in SRY-Negative 46,XX Individuals: Clinical and Genetic Aspects
  69. Diagnosis and Treatment of Disorders of Sexual Development∗
  70. Hormonal Changes in Childhood and Puberty
  71. Compensatory function of the remaining testis is dissociated in boys and adolescents with monorchidism
  72. Fertility Issues in Disorders of Sex Development
  73. Hypogonadotropic Hypogonadism in Infants with Congenital Hypopituitarism: A Challenge to Diagnose at an Early Stage
  74. When hormone defects cannot explain it: Malformative disorders of sex development
  75. Spreading the Clinical Window for Diagnosing Fetal-Onset Hypogonadism in Boys
  76. Mini-puberty and true puberty: Differences in testicular function
  77. Fertility Issues in the Management of Patients with Disorders of Sex Development
  78. Testicular function during adolescence in boys with type 1 diabetes mellitus (T1D): absence of hypogonadism and differences in endocrine profile at the beginning and end of puberty
  79. Prediction of Reproductive Outcomes According to Different Serum Anti-Müllerian Hormone Levels in Females Undergoing Intracystoplasmic Sperm Injection
  80. The prepubertal testis
  81. Prenatal testosterone programming: ontogeny of changes in testis of fetal and prepubertal male sheep
  82. Anti-Mullerian hormone: a Sertoli cell hormone that can be used as a predictor of male hypogonadism
  83. Anti-Müllerian Hormone: A Valuable Addition to the Toolbox of the Pediatric Endocrinologist
  84. HeterozygousIGFALSGene Variants in Idiopathic Short Stature and Normal Children: Impact on Height and the IGF System
  85. Accelerated early pubertal progression, ovarian morphology, and ovarian function in prospectively followed low birth weight (LBW) girls
  86. Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
  87. Serum AMH level can predict the risk of cycle cancellation and the chances of good ovarian response, independently of patient's age or FSH
  88. Early Orchiopexy to Prevent Germ Cell Loss during Infancy in Congenital Cryptorchidism
  89. Altered testicular development as a consequence of increase number of sertoli cell in male lambs exposed prenatally to excess testosterone
  90. Testicular Anti-Müllerian Hormone: Clinical Applications in DSD
  91. Decline in serum antimüllerian hormone due to androgen action in early puberty in males
  92. Differential Regulation of Ovarian Anti-Müllerian Hormone (AMH) by Estradiol through α- and β-Estrogen Receptors
  93. Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness
  94. Disorders of Sex Development and Hypogonadism: Genetics, Mechanism, and Therapies
  95. Clinical Presentation of Klinefelter's Syndrome: Differences According to Age
  96. Sertoli cell markers in the diagnosis of paediatric male hypogonadism
  97. New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker
  98. Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21
  99. SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1
  100. FSH and Its Second Messenger cAMP Stimulate the Transcription of Human Anti-Müllerian Hormone in Cultured Granulosa Cells
  101. Normal male sexual differentiation and aetiology of disorders of sex development
  102. Are Klinefelter boys hypogonadal?
  103. Elevated anti-Müllerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus
  104. Prenatal testosterone excess alters Sertoli and germ cell number and testicular FSH receptor expression in rams
  105. Basal Follicle-Stimulating Hormone and Peak Gonadotropin Levels after Gonadotropin-Releasing Hormone Infusion Show High Diagnostic Accuracy in Boys with Suspicion of Hypogonadotropic Hypogonadism
  106. Origin and evolution of somatic cell testicular tumours in transgenic mice
  107. Anti-Müllerian Hormone and Sertoli Cell Function in Paediatric Male Hypogonadism
  108. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: Its relevance on Sertoli cell maturation and the onset of adult spermatogenesis
  109. Anti-Müllerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus
  110. Normal and abnormal female sexual differentiation
  111. FSH and bFGF stimulate the production of glutathione in cultured rat Sertoli cells
  112. Lack of Androgen Receptor Expression in Sertoli Cells Accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development
  113. Lack of Androgen Receptor Expression in Sertoli Cells Accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development
  114. Lack of Androgen Receptor Expression in Sertoli Cells accounts for the Absence of Anti-Mullerian Hormone Repression during Early Human Testis Development
  115. Klinefelter Syndrome and Cryptorchidism
  116. Physiological Androgen Insensitivity of the Fetal, Neonatal, and Early Infantile Testis Is Explained by the Ontogeny of the Androgen Receptor Expression in Sertoli Cells
  117. Pituitary and Testicular Function in Sons of Women with Polycystic Ovary Syndrome from Infancy to Adulthood
  118. Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
  119. Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome
  120. Activation of Melanocortin 4 Receptors Reduces the Inflammatory Response and Prevents Apoptosis Induced by Lipopolysaccharide and Interferon-γ in Astrocytes
  121. Predictive Value of Anatomical Findings and Karyotype Analysis in the Diagnosis of Patients with Disorders of Sexual Development
  122. Seminiferous tubule function in delayed-onset X-linked adrenal hypoplasia congenita associated with incomplete hypogonadotrophic hypogonadism
  123. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune–Albright syndrome
  124. Time Course of the Serum Gonadotropin Surge, Inhibins, and Anti-Müllerian Hormone in Normal Newborn Males during the First Month of Life
  125. Mitotic activity of Sertoli cells in adult human testis: an immunohistochemical study to characterize Sertoli cells in testicular cords from patients showing testicular dysgenesis syndrome
  126. Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias
  127. Anti-Müllerian hormone in disorders of sex determination and differentiation
  128. Testicular Anti-Müllerian Hormone Secretion Is Stimulated by Recombinant Human FSH in Patients with Congenital Hypogonadotropic Hypogonadism
  129. Differentiation markers of Sertoli cells and germ cells in fetal and early postnatal human testis
  130. Subcellular and Molecular Mechanisms Regulating Anti-Müllerian Hormone Gene Expression in Mammalian and Nonmammalian Species
  131. Subcellular and Molecular Mechanisms Regulating Anti-Müllerian Hormone Gene Expression in Mammalian and Nonmammalian Species
  132. Altered serum profile of inhibin B, Pro-alphaC and anti-Mullerian hormone in prepubertal and pubertal boys with varicocele
  133. AMH/MIS: what we know already about the gene, the protein and its regulation
  134. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans
  135. Follicle-Stimulating Hormone Increases Testicular Anti-Müllerian Hormone (AMH) Production through Sertoli Cell Proliferation and a Nonclassical Cyclic Adenosine 5′-Monophosphate-Mediated Activation of the AMH Gene
  136. Anti-Müllerian Hormone
  137. Age dependent changes in plasma anti-Müllerian hormone concentrations in the bovine male, female, and freemartin from birth to puberty: relationship between testosterone production and influence on sex differentiation
  138. Altered expression of connexins 26 and 43 in Sertoli cells in seminiferous tubules infiltrated with carcinoma-in-situ or seminoma
  139. Aetiological diagnosis of male sex ambiguity: a collaborative study
  140. Sertoli Cell Proliferations of the Infantile Testis
  141. Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice
  142. Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Müllerian Hormone in Transgenic Mice
  143. DIFERENCIACIÓN SEXUAL EMBRIO-FETAL: DE LAS MOLÉCULAS A LA ANATOMIA
  144. Macroorchidism due to Autonomous Hyperfunction of Sertoli Cells and Gs  Gene Mutation: An Unusual Expression of McCune-Albright Syndrome in a Prepubertal Boy
  145. Anti-Müllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors
  146. Assessment of seminiferous tubule function (anti-müllerian hormone)
  147. L'intérêt du dosage de l'hormone anti-mullérienne en clinique humaine
  148. Detection of Minimal Levels of Serum Anti-Mullerian Hormone during Follow-Up of Patients with Ovarian Granulosa Cell Tumor by Means of a Highly Sensitive Enzyme-Linked Immunosorbent Assay
  149. Antimüllerian Hormone in Patients with Hypogonadotropic Hypogonadism
  150. Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia
  151. Presence of anti-Müllerian hormone correlates with absence of laminin α5 chain in differentiating rat testis and ovary
  152. Evaluation of Gonadal Function in 107 Intersex Patients by Means of Serum Antimullerian Hormone Measurement
  153. Retained Müllerian Ducts
  154. Reversion of the differentiated phenotype and maturation block in Sertoli cells in pathological human testis
  155. The role of anti-Müllerian hormone in gonadal development
  156. Endocrine, Paracrine and Cellular Regulation of Postnatal Anti-Müllerian Hormone Secretion by Sertoli Cells
  157. Embryology and endocrinology of genital development
  158. Inhibin B Is the Major Form of Inhibin/Activin Family Secreted by Granulosa Cell Tumors
  159. Inhibin B Is the Major Form of Inhibin/Activin Family Secreted by Granulosa Cell Tumors
  160. Receptors for anti-Müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation
  161. A mouse Sertoli cell line expressing anti-Müllerian hormone and its type II receptor
  162. Clinical aspects and molecular genetics of the persistent Mullerian duct syndrome
  163. A 27 base-pair deletion of the anti-mullerian type II receptor gene is the most common cause of the persistent mullerian duct syndrome
  164. Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent Müllerian ducts in a Turkish boy born to consanguineous parents
  165. Genetic mechanisms of sex differentiation
  166. Antimullerian Hormone As a Serum Marker of Granulosa Cell Tumors of the Ovary
  167. Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum α-inhibin and estradiol
  168. Morphometric study of the testicular interstitial tissue of the monkey Cebus apella during postnatal development
  169. Testicular Steroidogenesis in the Cebus Monkey throughout Postnatal Development1
  170. Testicular degeneration in three patients with the persistent müllerian duct syndrome
  171. Testicular degeneration in three patients with the persistent M�llerian duct syndrome
  172. La cellule de Sertoli, une cellule endocrine
  173. Anti-mullerian hormone in children with androgen insensitivity
  174. Molecular genetics of the persistent Mullerian duct syndrome: a study of 19 families
  175. Anti-mullerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development
  176. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development.
  177. Is infancy a quiescent period of testicular development? Histological, morphometric, and functional study of the seminiferous tubules of the cebus monkey from birth to the end of puberty
  178. Is infancy a quiescent period of testicular development? Histological, morphometric, and functional study of the seminiferous tubules of the cebus monkey from birth to the end of puberty.